Old-Fashioned Mitotic Count May Outperform Ki67 in Hormone Receptor-Positive Breast Cancer
A Norwegian population-based study finds that the manual mitotic count retains independent prognostic value in hormone receptor-positive, HER2-negative breast cancer ...
